vcvibes

Arch Venture Partners

ARCH Venture Fund XII, L.P.

Late investment period

Late investment period: first sale Feb 2022, per Form D (fund age approximates vintage)

Visit their website
Vintage
2022
Fund size
$2810M to $3082.22M (Form D and SEC adviser filing)
Stages
Not stated
Sectors
Biotech
Regions
Global

01 · Thesis

ARCH backs disruptive science companies, following the science to found companies based on revolutionary technologies. It takes a long-term view, sizing portfolio investments as needed and partnering through formation stages toward full potential.Inferred from the firm's website

02 · Initial check

$28.1M to $51.37M (estimated from fund size)

Estimated from Form D and SEC adviser filing

03 · Who to approach

Named on this fund's Form D

  • Steve Gillis, Ph.D., Managing Director
  • Mark McDonnell, Managing Director, CFO & CAO
  • Keith Crandell, Co-founder & Managing Director
  • Jason Doren, General Counsel
  • Paul Berns, Managing Director
  • Kristina Burow, Managing Director
  • Robert Nelsen, Co-founder & Managing Director

04 · Deals

No deals attributed to this fund yet.

05 · Evidence

  • Firm-wideARCH backs disruptive science companies, following the science to found companies based on revolutionary technologies.

    We follow the science to found companies based on revolutionary technologies that can impact people’s lives.
    https://www.archventure.com/about/

06 · Sources

  1. https://www.archventure.com/about/
  2. https://www.sec.gov/Archives/edgar/data/1906837/000101297522000145/

Last verified: Oct 28, 2026